正清风痛宁联合常规类风湿关节炎治疗的临床多中心回顾性研究

IF 3 3区医学 Q1 INTEGRATIVE & COMPLEMENTARY MEDICINE

Journal of Traditional and Complementary Medicine Pub Date : 2025-10-01 DOI:10.1016/j.jtcme.2024.08.005

Ze Yu , Zan Li , Ya Gao , Chunming Lyu , Fang Kou , Jialong Guo , Fei Gao , Hai Wei

{"title":"正清风痛宁联合常规类风湿关节炎治疗的临床多中心回顾性研究","authors":"Ze Yu , Zan Li , Ya Gao , Chunming Lyu , Fang Kou , Jialong Guo , Fei Gao , Hai Wei","doi":"10.1016/j.jtcme.2024.08.005","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Zhengqing Fengtongning (ZF) is a modern traditional Chinese medicine preparation used to treat rheumatoid arthritis (RA). In this study, we aimed to prove the effectiveness of ZF in combination with routine RA treatment in the real world.</div></div><div><h3>Methods</h3><div>This was a retrospective study including 3877 RA patients in multi-centers from August 2015 to April 2023. The experimental group received ZF and the control group received other RA regimens. Propensity score matching was used to eliminate bias. The effectiveness of ZF in combination with routine RA treatment was evaluated through DAS28, ESR, CRP and RF.</div></div><div><h3>Results</h3><div>The effectiveness of combining ZF with methotrexate (MTX), iguratimod (IGU), leflunomide (LEF), MTX + LEF, and MTX + nonsteroidal anti-inflammatory drugs in treating RA was significantly better than that of not combining ZF (<em>p</em> < 0.05). The effectiveness of combining ZF was significantly better than that of combining total glucosides of paeony, Kunxian capsule, or Biqi capsule (<em>p</em> < 0.05). No significant difference existed in effectiveness among MTX, IGU, and ZF combined with JAK inhibitor or TNF-ɑ inhibitor (<em>p</em> > 0.05).</div></div><div><h3>Conclusions</h3><div>This study provides evidence that the effectiveness of MTX, IGU, LEF, MTX + LEF, and MTX + NSAIDs combined with ZF in treating RA was better than those without ZF.</div></div>","PeriodicalId":17449,"journal":{"name":"Journal of Traditional and Complementary Medicine","volume":"15 6","pages":"Pages 591-600"},"PeriodicalIF":3.0000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Effectiveness of Zhengqing Fengtongning in combination with routine rheumatoid arthritis treatment: A real-world multicenter retrospective study\",\"authors\":\"Ze Yu , Zan Li , Ya Gao , Chunming Lyu , Fang Kou , Jialong Guo , Fei Gao , Hai Wei\",\"doi\":\"10.1016/j.jtcme.2024.08.005\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><div>Zhengqing Fengtongning (ZF) is a modern traditional Chinese medicine preparation used to treat rheumatoid arthritis (RA). In this study, we aimed to prove the effectiveness of ZF in combination with routine RA treatment in the real world.</div></div><div><h3>Methods</h3><div>This was a retrospective study including 3877 RA patients in multi-centers from August 2015 to April 2023. The experimental group received ZF and the control group received other RA regimens. Propensity score matching was used to eliminate bias. The effectiveness of ZF in combination with routine RA treatment was evaluated through DAS28, ESR, CRP and RF.</div></div><div><h3>Results</h3><div>The effectiveness of combining ZF with methotrexate (MTX), iguratimod (IGU), leflunomide (LEF), MTX + LEF, and MTX + nonsteroidal anti-inflammatory drugs in treating RA was significantly better than that of not combining ZF (<em>p</em> < 0.05). The effectiveness of combining ZF was significantly better than that of combining total glucosides of paeony, Kunxian capsule, or Biqi capsule (<em>p</em> < 0.05). No significant difference existed in effectiveness among MTX, IGU, and ZF combined with JAK inhibitor or TNF-ɑ inhibitor (<em>p</em> > 0.05).</div></div><div><h3>Conclusions</h3><div>This study provides evidence that the effectiveness of MTX, IGU, LEF, MTX + LEF, and MTX + NSAIDs combined with ZF in treating RA was better than those without ZF.</div></div>\",\"PeriodicalId\":17449,\"journal\":{\"name\":\"Journal of Traditional and Complementary Medicine\",\"volume\":\"15 6\",\"pages\":\"Pages 591-600\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Traditional and Complementary Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2225411024001020\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"INTEGRATIVE & COMPLEMENTARY MEDICINE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Traditional and Complementary Medicine","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2225411024001020","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}

引用次数: 0

摘要

正清风痛宁（ZF）是一种治疗类风湿性关节炎（RA）的现代中药制剂。在这项研究中，我们的目的是在现实世界中证明ZF联合常规RA治疗的有效性。方法回顾性研究，纳入2015年8月至2023年4月多中心3877例RA患者。实验组给予ZF治疗，对照组给予其他RA治疗方案。倾向评分匹配用于消除偏差。通过DAS28、ESR、CRP、RF评价ZF联合常规RA治疗的有效性。结果ZF联合甲氨蝶呤（MTX）、iguratimod （IGU）、来氟米特（LEF）、MTX + LEF、MTX +非甾体抗炎药治疗RA的疗效显著优于不联合ZF组（p < 0.05）。联合用药效果显著优于丹参总苷、坤仙胶囊和痹气胶囊（p < 0.05）。MTX、IGU和ZF联合JAK抑制剂或TNF-抑制剂的疗效无显著差异（p > 0.05）。结论MTX、IGU、LEF、MTX + LEF、MTX +非甾体抗炎药联合ZF治疗RA的疗效优于非ZF组。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Effectiveness of Zhengqing Fengtongning in combination with routine rheumatoid arthritis treatment: A real-world multicenter retrospective study

查看原文本刊更多论文

Effectiveness of Zhengqing Fengtongning in combination with routine rheumatoid arthritis treatment: A real-world multicenter retrospective study

Background

Zhengqing Fengtongning (ZF) is a modern traditional Chinese medicine preparation used to treat rheumatoid arthritis (RA). In this study, we aimed to prove the effectiveness of ZF in combination with routine RA treatment in the real world.

Methods

This was a retrospective study including 3877 RA patients in multi-centers from August 2015 to April 2023. The experimental group received ZF and the control group received other RA regimens. Propensity score matching was used to eliminate bias. The effectiveness of ZF in combination with routine RA treatment was evaluated through DAS28, ESR, CRP and RF.

Results

The effectiveness of combining ZF with methotrexate (MTX), iguratimod (IGU), leflunomide (LEF), MTX + LEF, and MTX + nonsteroidal anti-inflammatory drugs in treating RA was significantly better than that of not combining ZF (p < 0.05). The effectiveness of combining ZF was significantly better than that of combining total glucosides of paeony, Kunxian capsule, or Biqi capsule (p < 0.05). No significant difference existed in effectiveness among MTX, IGU, and ZF combined with JAK inhibitor or TNF-ɑ inhibitor (p > 0.05).

Conclusions

This study provides evidence that the effectiveness of MTX, IGU, LEF, MTX + LEF, and MTX + NSAIDs combined with ZF in treating RA was better than those without ZF.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Traditional and Complementary Medicine Medicine-Complementary and Alternative Medicine

CiteScore

9.30

自引率

6.70%

发文量

审稿时长

66 days

期刊介绍： eJTCM is committed to publish research providing the biological and clinical grounds for using Traditional and Complementary Medical treatments as well as studies that demonstrate the pathophysiological and molecular/biochemical bases supporting the effectiveness of such treatments. Review articles are by invitation only. eJTCM is receiving an increasing amount of submission, and we need to adopt more stringent criteria to select the articles that can be considered for peer review. Note that eJTCM is striving to increase the quality and medical relevance of the publications.